Mitsui Chemicals has reported sales of 67.5 billion Japanese yen (€417 million) for its Life & Healthcare unit in the first quarter of 2024-25, up by 18.2 percent year over year. The division’s operation profit margin for the quarter gained 0.7 percentage points versus Q1 2023-24, reaching 8.6 percent.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.